Navigation Links
Vion Reports 2008 Third Quarter and Nine-Month Results
Date:11/3/2008

n.

Alan Kessman, Chief Executive Officer, commented, "We continue to focus on the preparation of the New Drug Application (NDA) for our lead anticancer agent laromustine (Cloretazine, VNP40101M). The NDA filing will be based on our two Phase II trials in elderly patients with acute myelogenous leukemia. Our plan is to file this NDA in early 2009."

Third Quarter Conference Call

The Company announced that it would hold a conference call on Thursday, November 6, 2008 to discuss its 2008 third quarter financial results. The call will begin at 8:30 a.m. Eastern Time.

To participate in the conference call, please dial (800) 831-6270 in the U.S. ((617) 213-8858 for international callers) at least 15 minutes before the start of the call. When prompted for a pass code, please enter 85439318.

An audio webcast of the call will be accessible at http://www.vionpharm.com. Those who wish to listen to the conference call on the Web should visit the Investor Relations section of the Company's website at least 15 minutes prior to the event broadcast, and follow the instructions provided to assure that the necessary audio applications are downloaded and installed. These programs can be obtained at no charge to the user.

A replay of the call will be available two hours after the completion of the call at (888) 286-8010 in the U.S., ((617) 801-6888 for international callers), pass code 37383579. The replay will be available through Thursday, November 20, 2008.

About Vion

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Laromustine (Cloretazine(R), VNP40101M), a unique alkylating agent, is being evaluated in a Phase II pivotal trial as a single agent in elderly patients with previously untreated de no
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008
2. Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options
3. NxStage Reports Third Quarter 2008 Financial Results
4. Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding
5. The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance
6. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. Nuvelo Reports Third Quarter 2008 Financial Results
9. Claimsnet.com Reports Third Quarter 2008 Results
10. Remuda Ranch Reports Many Individuals With Eating Disorders Are Not Getting Help They Need
11. Palomar Medical Reports Financial Results for Third Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 Carol Fenster, a pioneering expert ... Quick Gluten-Free Recipes (Houghton Mifflin Harcourt, 2014)—that makes ... Fenster believes that cooking gluten-free food can be fun, ... lifestyle doesn’t leave much time for food preparation. ... me is how to shorten their time in the ...
(Date:8/26/2014)... Leelanau Peninsula, MI (PRWEB) August 27, 2014 ... Stompede event is a fabulous time to visit the ... providing a magnificent backdrop to wine tasting fun in ... 7, 2014. , Kicking off the festivities is an ... Saturday at Ciccone Vineyards in Suttons Bay. A unique ...
(Date:8/26/2014)... Atlanta, GA (PRWEB) August 27, 2014 ... Atlanta area location, Atlanta Hearing Associates has expanded its professional ... team is Dr. Stephanie Collins . Atlanta Hearing ... care professionals who display a passionate commitment to patient ... aid technology and hearing loss treatments. The practice has grown ...
(Date:8/26/2014)... NJ (PRWEB) August 27, 2014 ... Practitioners, announced today that Purdue Pharma L.P. will ... Thursday, September 4 at PAINWeek 2014, convening next ... course offerings, symposia and special sessions designed to ... opioids, as well as on the increasingly stringent ...
(Date:8/26/2014)... Recently, Top10BestSEOHosting.com, the famous SEO hosting ... suppliers and announced that Bluehost ( http://www.bluehost.com/track/seohosts ), ... hosting suppliers in 2014. , “Cheap hosting is ... money,” the development manager of op10BestSEOHosting.com states, “It ... supplier. Actually, these companies have outperformed their competitors ...
Breaking Medicine News(10 mins):Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 2Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 3Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 2Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 3Health News:Atlanta Hearing Associates Needs New Audiologists to Its Professional Staff 2Health News:Atlanta Hearing Associates Needs New Audiologists to Its Professional Staff 3Health News:Purdue Pharma L.P. to Sponsor Opioid Awareness Day at PAINWeek 2014 2Health News:SEO Hosting Review Site Top10BestSEOHosting.com Recommends Bluehost, JustHost and Arvixe To Worldwide People 2
... MIDDLEBURG HEIGHTS, Ohio, May 27 Allscripts announced ... selected Allscripts Professional(R) Electronic Health Record ... in multi-specialty practices across suburban Cleveland, Ohio. (Logo: ... care hospital and health center with its own ...
... A growing body of research was presented at ... American Academy of Physician Assistants (AAPA) 37th Annual Conference. ... educational bridge to consumers and they desire to know ... them to their patients. The symposium brought together scientific ...
... Americans currently take medication to manage their symptoms of ... untreated for ADHD - partially because the process can ... magazine aims to simplify things with expert explanations of ... more. NEW YORK, May 27 ADDitude ...
... Translational Genomics Research Institute (TGen) and the University of ... cancer, Stand Up to Cancer (SU2C) announced today. , ... B. Thompson, Director of the Abramson Cancer Center at ... which will lead a three-year investigation into new approaches ...
... 27 PRA International, a leading Clinical Research Organization, ... its Sao Paulo, Brazil office. Drug Safety Centers are ... unit. They are staffed with drug safety professionals who ... Reaction management. Furthermore, our drug safety personnel support ...
... 27 The Providence Service Corporation (Nasdaq: ... of the proxy statement filed last week by the ... believes that the Avalon Group,s proxy statement contains numerous ... is necessary for it to correct the public record ...
Cached Medicine News:Health News:Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record 2Health News:Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record 3Health News:Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record 4Health News:Southwest General Health Center Selects Allscripts Web-Hosted Electronic Health Record 5Health News:Interest Surging in Probiotic Foods that Promote Health 2Health News:Interest Surging in Probiotic Foods that Promote Health 3Health News:Interest Surging in Probiotic Foods that Promote Health 4Health News:ADHD Treatment Guide: How to Safely, Effectively Use Medications and Non-Drug Therapies to Treat Attention Deficit Disorder 2Health News:$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research 2Health News:$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research 3Health News:$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research 4Health News:$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research 5Health News:PRA International Opens Additional Drug Safety Center in Sao Paulo, Brazil 2Health News:PRA International Opens Additional Drug Safety Center in Sao Paulo, Brazil 3Health News:Providence Service Corporation Rebuts False and Misleading Statements Contained in Proxy Statement Filed by the Avalon Group 2Health News:Providence Service Corporation Rebuts False and Misleading Statements Contained in Proxy Statement Filed by the Avalon Group 3
(Date:8/26/2014)... Del. , Aug. 26, 2014 Biomedical ... it has been named to the prestigious 2014 Inc. ... are honored to be included on this prestigious list ... said Chris Jacob , Biomedical Research Laboratories, CEO. ... and further serves to validate the hard work and ...
(Date:8/26/2014)... 2014 Acelleron Medical Products of North ... ., is expanding.  Acelleron, a home medical equipment provider, recently ... Acelleron Maternal Health & Wellness (MHW), to offer a wider ... range of resources for pregnant women and families. ... of maternal wellness. Vecchi, the former owner of Maternal Health ...
(Date:8/26/2014)... , Aug. 26, 2014  Sorrento Therapeutics, ... late-stage clinical oncology company developing new treatments for ... it has received funding to advance an immunotherapy ... treatment of IPF, which affects more than 100,000 ... lungs increases and patients gradually lose the ability ...
Breaking Medicine Technology:Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3
... ConvaTec, a world-leading developer and marketer of innovative medical ... appointment of several executives to new positions within the ... President, Intercontinental in a newly aligned region that will ... continue to be a strategic focus for growth for ...
... MAPLE GROVE, Minn., Feb. 7, 2011 Upsher-Smith Laboratories, Inc. ... vitamin, the newest addition to the Nexa™ Prenatal Vitamin ... Vitamin D3 (800 IU). Its advanced formulation offers more plant-based ... taken once a day.  Many experts recommend a DHA intake ...
Cached Medicine Technology:ConvaTec Announces New Appointments to Leadership Team 2Upsher-Smith Introduces Nexa™ Select With More Plant-Based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin 2Upsher-Smith Introduces Nexa™ Select With More Plant-Based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin 3Upsher-Smith Introduces Nexa™ Select With More Plant-Based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin 4
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products: